Novel GPIb-independent platelet aggregation induced by botrocetin: implications for diagnosis and antithrombotic therapy
Journal of Thrombosis and Haemostasis · 2024
DOI: 10.1016/j.jtha.2024.06.030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2024. Verfasst von Chuanbin Shen und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada; Department of Laboratory Medicine, Li Ka Shing K…. Hauptthemen laut MEDLINE: Platelet Aggregation, Platelet Glycoprotein GPIb-IX Complex, Blood Platelets, von Willebrand Factor. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: Hospital for Sick Children, National Institutes of Health, Canadian Institutes of Health Research.
Abstract (Originalsprache)
BACKGROUND: Snake venom botrocetin facilitates von Willebrand factor (VWF) binding to platelet GPIbα and has been widely used for the diagnosis of von Willebrand disease and GPIb-related disorders. Botrocetin is also commonly employed for the development/characterization of antithrombotics targeting the GPIb-VWF axis. OBJECTIVES: To explore the alternative receptor(s)/mechanisms that participate in botrocetin-induced platelet aggregation. METHODS: The effects of botrocetin on platelet aggregation were examined using platelets from wild-type, VWF- and fibrinogen-deficient, GPIbα-deficient, IL4Rα/GPIbα-transgenic, ITGA2B and ITGB3-deficient mice, and Bernard-Soulier syndrome and healthy human samples. Platelet-fibrinogen and platelet-VWF interaction were measured using flow cytometry. GPIbα-VWF binding was evaluated utilizing enzyme-linked immunosorbent assay. Botrocetin-αIIbβ3 and botrocetin-GPIbα interactions were measured using enzyme-linked immunosorbent assay and fluorescence anisotropy assays. Heparinized whole blood from healthy donors was examined for thrombus formation and growth in a perfusion chamber. RESULTS: Botrocetin could induce aggregation of platelets from a Bernard-Soulier syndrome patient and GPIbα-deficient mice as well as platelets lacking the N-terminal extracellular domain of GPIbα. Botrocetin could interact with αIIbβ3 and facilitated αIIbβ3-VWF interaction independent of GPIb. Botrocetin competitively bound to the ligand-binding domain of activated rather than resting αIIbβ3. Although botrocetin-induced platelet aggregation requires VWF, strikingly, in the absence of VWF, botrocetin blocked fibrinogen and other ligand binding to αIIbβ3 and inhibited platelet aggregation and thrombus formation. Consistently, recombinant botrocetin defective in VWF binding inhibited αIIbβ3- and GPIb-mediated platelet aggregation, spreading, and thrombus formation. CONCLUSION: Our study provides insights into avoiding the misdiagnosis of GPIb-related disorders and developing botrocetin mutants as potential new antithrombotics that may simultaneously target both αIIbβ3 and GPIbα.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada; Department of Laboratory Medicine, Li Ka Shing Knowledge Institute (LKSKI)-Keenan Research Centre for Biomedical Scien…
- Department of Laboratory Medicine, Li Ka Shing Knowledge Institute (LKSKI)-Keenan Research Centre for Biomedical Science, St. Michael's Hospital, and Toronto Platelet Immunobiology Group, Toronto, Ontario, Canada; Depar…
- Department of Laboratory Medicine, Li Ka Shing Knowledge Institute (LKSKI)-Keenan Research Centre for Biomedical Science, St. Michael's Hospital, and Toronto Platelet Immunobiology Group, Toronto, Ontario, Canada; CCOA…
- Department of Laboratory Medicine, Li Ka Shing Knowledge Institute (LKSKI)-Keenan Research Centre for Biomedical Science, St. Michael's Hospital, and Toronto Platelet Immunobiology Group, Toronto, Ontario, Canada.
- Department of Laboratory Medicine, Li Ka Shing Knowledge Institute (LKSKI)-Keenan Research Centre for Biomedical Science, St. Michael's Hospital, and Toronto Platelet Immunobiology Group, Toronto, Ontario, Canada; Canad…
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Key Laboratory of Gene Therap…
Förderung
- Hospital for Sick Children
- National Institutes of Health
- Canadian Institutes of Health Research
- University of Toronto
Zitieren
APA
Shen, C., Mackeigan, D. T., Shoara, A. A., Bhoria, P., Zhu, G., Karakas, D., Ma, W., Chen, Z. Y., Xu, R., Slavkovic, S., Zhang, D., Prifti, V., Liu, Z., Cerenzia, E. G., Chen, P., Neves, M. A. D., Li, H., Xue, F., Yang, R., …, & Ni, H. (2024). Novel GPIb-independent platelet aggregation induced by botrocetin: implications for diagnosis and antithrombotic therapy. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2024.06.030
Vancouver
Shen C, Mackeigan DT, Shoara AA, Bhoria P, Zhu G, Karakas D, et al. Novel GPIb-independent platelet aggregation induced by botrocetin: implications for diagnosis and antithrombotic therapy. Journal of Thrombosis and Haemostasis. 2024. doi:10.1016/j.jtha.2024.06.030
BibTeX
@article{Shen2024,
author = {Shen, Chuanbin and Mackeigan, Daniel T and Shoara, Aron A and Bhoria, Preeti and Zhu, Guangheng and Karakas, Danielle and Ma, Wenjing and Chen, Zi Yan and Xu, Runjia and Slavkovic, Sladjana and Zhang, Dachuan and Prifti, Viktor and Liu, Zhenze and Cerenzia, Eric G and Chen, Pingguo and Neves, Miguel A D and Li, Huiyuan and Xue, Feng and Yang, Renchi and Liu, Junling and Lai, Ren and Li, Renhao and Ni, Heyu},
title = {Novel GPIb-independent platelet aggregation induced by botrocetin: implications for diagnosis and antithrombotic therapy},
journal = {Journal of Thrombosis and Haemostasis},
year = {2024},
doi = {10.1016/j.jtha.2024.06.030}
}
EUVIMED